These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

127 related items for PubMed ID: 2628072

  • 1. Characterization of a human tumour cell line panel for screening of anti-tumour agents in vitro.
    Fricker SP, Buckley RG.
    Biochem Soc Trans; 1989 Dec; 17(6):1049-50. PubMed ID: 2628072
    [No Abstract] [Full Text] [Related]

  • 2. Chemosensitivity testing of fresh human leukemia cells using both a dye exclusion assay and a tetrazolium dye (MTT) assay.
    Kirkpatrick DL, Duke M, Goh TS.
    Leuk Res; 1990 Dec; 14(5):459-66. PubMed ID: 2345469
    [Abstract] [Full Text] [Related]

  • 3. Comparison of the rapid automated MTT-assay with a dye exclusion assay for chemosensitivity testing in childhood leukaemia.
    Pieters R, Huismans DR, Leyva A, Veerman AJ.
    Br J Cancer; 1989 Feb; 59(2):217-20. PubMed ID: 2930687
    [No Abstract] [Full Text] [Related]

  • 4. Chemosensitivity testing of human lung cancer cell lines using the MTT assay.
    Carmichael J, Mitchell JB, DeGraff WG, Gamson J, Gazdar AF, Johnson BE, Glatstein E, Minna JD.
    Br J Cancer; 1988 Jun; 57(6):540-7. PubMed ID: 2841961
    [Abstract] [Full Text] [Related]

  • 5. Comparison of in vitro anticancer-drug-screening data generated with a tetrazolium assay versus a protein assay against a diverse panel of human tumor cell lines.
    Rubinstein LV, Shoemaker RH, Paull KD, Simon RM, Tosini S, Skehan P, Scudiero DA, Monks A, Boyd MR.
    J Natl Cancer Inst; 1990 Jul 04; 82(13):1113-8. PubMed ID: 2359137
    [Abstract] [Full Text] [Related]

  • 6. [A tumor sensitivity test, SDI test using XTT].
    Kondo T, Tatematsu A, Sato Y, Ishikawa M.
    Gan To Kagaku Ryoho; 1991 Jan 04; 18(1):123-6. PubMed ID: 1987893
    [No Abstract] [Full Text] [Related]

  • 7. Assessment of antineoplastic agents by MTT assay: partial underestimation of antiproliferative properties.
    Sobottka SB, Berger MR.
    Cancer Chemother Pharmacol; 1992 Jan 04; 30(5):385-93. PubMed ID: 1505077
    [Abstract] [Full Text] [Related]

  • 8. The clinical benefit of the histoculture drug response assay.
    Hoffman RM.
    Gan To Kagaku Ryoho; 2000 May 04; 27 Suppl 2():321-2. PubMed ID: 10895174
    [No Abstract] [Full Text] [Related]

  • 9. The hollow fiber assay.
    Hall LA, Krauthauser CM, Wexler RS, Slee AM, Kerr JS.
    Methods Mol Med; 2003 May 04; 74():545-66. PubMed ID: 12415720
    [No Abstract] [Full Text] [Related]

  • 10. Comparison of chemosensitivity tests: clonogenic assay versus MTT assay.
    Kawada K, Yonei T, Ueoka H, Kiura K, Tabata M, Takigawa N, Harada M, Tanimoto M.
    Acta Med Okayama; 2002 Jun 04; 56(3):129-34. PubMed ID: 12108583
    [Abstract] [Full Text] [Related]

  • 11. Evaluation of the relative cytotoxic effects of anticancer agents in serum-supplemented versus serum-free media using a tetrazolium colorimetric assay.
    Tsai CM, Perng RP, Chang KT, Venzon D, Gazdar AF.
    Jpn J Cancer Res; 1996 Jan 04; 87(1):91-7. PubMed ID: 8609055
    [Abstract] [Full Text] [Related]

  • 12. The MTT assay for chemosensitivity testing of human tumors of the central nervous system. Part II: Evaluation of patient- and drug-specific variables.
    Nikkhah G, Tonn JC, Hoffmann O, Kraemer HP, Darling JL, Schachenmayr W, Schönmayr R.
    J Neurooncol; 1992 May 04; 13(1):13-24. PubMed ID: 1613536
    [Abstract] [Full Text] [Related]

  • 13. [Estimating doses of anti-cancer agents in sensitivity tests in vitro].
    Kobayashi K, Takemoto T, Hino M, Hayashihara K, Nakahiro K, Wasai S, Niitani H.
    Gan To Kagaku Ryoho; 1992 Mar 04; 19(3):399-403. PubMed ID: 1543368
    [No Abstract] [Full Text] [Related]

  • 14. Assay of anticancer drugs in tissue culture: comparison of a tetrazolium-based assay and a protein binding dye assay in short-term cultures derived from human malignant glioma.
    Haselsberger K, Peterson DC, Thomas DG, Darling JL.
    Anticancer Drugs; 1996 May 04; 7(3):331-8. PubMed ID: 8792008
    [Abstract] [Full Text] [Related]

  • 15. [Sensitivity test of anti-tumor agents. 2. Application of MTT assay].
    Wada Y, Tomiyoshi Y, Fujimaru J, Ogura M, Yoshida S, Takeda Y.
    Gan To Kagaku Ryoho; 1991 Aug 04; 18(10):1587-92. PubMed ID: 1908212
    [Abstract] [Full Text] [Related]

  • 16. Predictability of in vivo chemosensitivity by in vitro MTT assay with reference to the clonogenic assay.
    Shimoyama Y, Kubota T, Watanabe M, Ishibiki K, Abe O.
    J Surg Oncol; 1989 May 04; 41(1):12-8. PubMed ID: 2716329
    [Abstract] [Full Text] [Related]

  • 17. Synthesis and cytotoxic activity of indolyl thiazoles.
    Moody CJ, Roffey JR, Stephens MA, Stratford IJ.
    Anticancer Drugs; 1997 Jun 04; 8(5):489-99. PubMed ID: 9215613
    [Abstract] [Full Text] [Related]

  • 18. [Chemosensitivity test for thyroid cancer by in vitro MTT assay].
    Sasaki F, Ishimura H, Takada N, Uchino J.
    Gan To Kagaku Ryoho; 1995 Oct 04; 22(12):1777-81. PubMed ID: 7574809
    [Abstract] [Full Text] [Related]

  • 19. The combination of the tetrazolium derivative reduction (MTT) and digital cell image analysis to monitor in vitro the cytotoxicity of anti-neoplastic drugs.
    Etievant C, Kruczynski A, Pauwels O, Kiss R.
    Anticancer Res; 1991 Oct 04; 11(1):305-11. PubMed ID: 2018364
    [Abstract] [Full Text] [Related]

  • 20. Comparison of two colorimetric assays as cytotoxicity endpoints for an in vitro screen for antitumour agents.
    Fricker SP, Buckley RG.
    Anticancer Res; 1996 Oct 04; 16(6B):3755-60. PubMed ID: 9042253
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.